This medication is available in the form of injection, administered by health care providers, intravenously.
• It is taken in the dose of 5-10 mg/kg body weight every 2 weeks with other chemotherapeutic agents for colorectal cancer
• For lung cancer: 15 mg/kg every 3 weeks with carboplatin and paclitaxel
• 10 mg/kg every 2 weeks for renal cancer
• The recommended dosage is 10 mg/kg intravenously every 2 weeks for glioblastoma.
• 15 mg/kg every 3 weeks with paclitaxel and cisplatin, or paclitaxel and topotecan for Stage III or IV ovarian, fallopian tube or peritoneal cancer after surgical resection.
IV infusion 5 or 10 mg/kg every 14 days in combination with IV 5-fluorouracil�based chemotherapy.
The recommended dosage is 5 mg/kg every 14 days when administered with irinotecan/5-fluorouracil/leucovorin, and 10 mg/kg every 14 days when administered with 5-fluorouracil/leucovorin/oxaliplatin.
Avastin.
• It is taken in the dose of 5-10 mg/kg body weight every 2 weeks with other chemotherapeutic agents for colorectal cancer
• For lung cancer: 15 mg/kg every 3 weeks with carboplatin and paclitaxel
• 10 mg/kg every 2 weeks for renal cancer
• The recommended dosage is 10 mg/kg intravenously every 2 weeks for glioblastoma.
• 15 mg/kg every 3 weeks with paclitaxel and cisplatin, or paclitaxel and topotecan for Stage III or IV ovarian, fallopian tube or peritoneal cancer after surgical resection.
Dosage & When it is to be taken
Metastatic Carcinoma of the Colon or Rectum - AdultsIV infusion 5 or 10 mg/kg every 14 days in combination with IV 5-fluorouracil�based chemotherapy.
The recommended dosage is 5 mg/kg every 14 days when administered with irinotecan/5-fluorouracil/leucovorin, and 10 mg/kg every 14 days when administered with 5-fluorouracil/leucovorin/oxaliplatin.
When it is not to be taken (Contraindications)
Contraindicated in patients with hole in stomach or intestine, wound, and hypersensitivity.Drug Name : Bevacizumab
This medication is used to treat certain types of advanced lung cancer.Trade Names/Brand Names of Bevacizumab
International :
Avastin.
